Comments
J&J drug shows promise in high-risk prostate cancer
17.05.2012. | (Reuters) - Adding Johnson & Johnson's advanced prostate cancer drug, Zytiga, to hormone therapy before surgery has been shown for the first time to eradicate tumors in some men with high-risk forms of the disease....
